AbbVie Inc. (ABBV) vs Johnson & Johnson (JNJ)
A side-by-side comparison of AbbVie Inc. and Johnson & Johnson across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
JNJ
Johnson & Johnson
$266.73HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABBV vs JNJ
growth of $100 · dividends reinvested · last 14yABBV +1164.7%JNJ +455.1%ABBV compounded faster
ABBV JNJ
ABBV vs JNJ: by the numbers
- •JNJ is the larger company ($642.79B vs $465.51B market cap).
- •JNJ trades at the lower trailing earnings multiple (30.82 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •JNJ converts more revenue to profit (21.48% vs 5.79% net margin).
- •ABBV grew revenue faster over the past five years (4.59% vs 2.93% CAGR).
- •ABBV pays the higher dividend yield (2.62% vs 1.97%).
Metrics side by side
Valuation
| Metric | ABBV | JNJ |
|---|---|---|
| P/E ratio | 125.98 | 30.82 |
| Forward P/E | N/A | 22.76 |
| P/S ratio | 7.26 | 6.63 |
| P/B ratio | 16.57 | 7.64 |
| PEG ratio | N/A | 0.21 |
| EV / EBITDA | 20.46 | 19.98 |
| FCF yield | 4.58% | 3.48% |
Profitability
| Metric | ABBV | JNJ |
|---|---|---|
| Gross margin | 70.68% | 70.45% |
| Operating margin | 27.60% | 26.81% |
| Net margin | 5.79% | 21.48% |
| ROE | 13.23% | 24.76% |
| ROIC | 12.97% | 13.71% |
Dividends
| Metric | ABBV | JNJ |
|---|---|---|
| Dividend yield | 2.62% | 1.97% |
| Payout ratio | 284.39% | 47.51% |
Growth (annualized)
| Metric | ABBV | JNJ |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 2.93% |
| EPS CAGR (5Y) | -2.79% | 11.51% |
| FCF CAGR (5Y) | 3.24% | -0.49% |
| Total return CAGR (5Y) | 21.24% | 12.13% |
Frequently asked
- Which has the lower trailing P/E, ABBV or JNJ?
- JNJ has the lower trailing P/E: ABBV trades at 125.98 and JNJ at 30.82. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or JNJ?
- Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus JNJ at 2.93%.
- Does ABBV or JNJ pay a bigger dividend?
- ABBV yields 2.62% and JNJ yields 1.97% based on trailing dividends and the latest price.
- Is ABBV or JNJ more profitable?
- JNJ runs the higher net margin — ABBV at 5.79% versus JNJ at 21.48%.
- How have ABBV and JNJ total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and JNJ delivered 10.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioJohnson & Johnson P/E ratioAbbVie dividend yieldJohnson & Johnson dividend yieldAbbVie ROEJohnson & Johnson ROEAbbVie operating marginJohnson & Johnson operating marginAbbVie revenue growthJohnson & Johnson revenue growthAbbVie free cash flowJohnson & Johnson free cash flow
AbbVie & Johnson & Johnson appear in these rankings
Highest Dividend Yield Stocks25+ Year Dividend GrowersHighest FCF Yield StocksHighest 10-Year Total Return Stocks
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.